Kevin Comcowich - 19 Aug 2024 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Director
Signature
Kevin Comcowich, by Attorney-in-fact, Solaeta Chan
Issuer symbol
RKDA
Transactions as of
19 Aug 2024
Transactions value $
$0
Form type
4
Date filed
21 Aug 2024, 19:06
Previous filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (Right to Buy) Award $0 +25.5K +455.61% $0.00 31K 19 Aug 2024 Common Stock 25.5K $2.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.